"Do not negate 184 years of debate": Bill rolling back Māori rights in New Zealand faces backlash
The controversial Treaty Principles Bill would end the Māori right of self-determination outlined in a nearly 200-year-old ...
Ignoring ACT, targeting National: The lead-up to the Treaty bill
The Treaty Principles Bill dominated Parliament's week. How was it talked about in the House before it was debated, who ...
Treaty Principles Bill: PM Christopher Luxon claps back at Act’s David Seymour, Te Pāti Māori delivers on dramatic day in Parliament
Act’s Treaty Principles Bill passed its first reading in Parliament on Thursday with support from National, Act and NZ First.
'Do the right thing': ACT's David Seymour hits out at schools encouraging students to join hīkoi
ACT leader David Seymour is warning principals they're technically public servants - and must display political neutrality.
Māori Lawmakers in New Zealand Disrupt Parliament With Protest ‘Haka’
Rawhiti Maipi-Clarke of Te Pāti Māori stood and began a rhythmic Māori chant of challenge, which swelled to a roar as ...
Hosted on MSN9mon
ACT leader David Seymour responds to being drowned out by protest waiata at Waitangi
He says those drowning him out were a small minority. 3:30pm - ACT Party leader David Seymour addresses the media. 3:25pm - "I came here expecting to be challenged and there to be a range of views ...
Labour's Willie Jackson ejected from house for calling David Seymour a liar during Treaty Principles Bill reading
The bill's champion and chief author, David Seymour, pushed back - saying "equal rights for all ... right across the board the government's doing a great job on these tough issues and ACT I would say ...
Scoop5d
Treaty Principles Bill Hīkoi Organiser Rejects David Seymour's Offer To Meet
Activists say they have no interest in meeting the Treaty Principles bill's backer, ACT party leader David Seymour, saying ...
devdiscourse11d
Medsafe Accelerates Medicine Approval Process, Seymour Calls for Further Reforms
The data highlights major efficiency gains, particularly in the assessment of new and generic medicines, as well as ...